Individualised vancomycin doses for paediatric burn patients to achieve PK/PD targets (2013)
- Authors:
- USP affiliated authors: FERREIRA, MARCUS CASTRO - FM ; SILVA JUNIOR, CARLINDO VIEIRA DA - FCF ; SANTOS, SILVIA REGINA CAVANI JORGE - FCF
- Unidades: FM; FCF
- DOI: 10.1016/j.burns.2012.07.005
- Subjects: QUEIMADURAS (TERAPIA); ESTUDOS PROSPECTIVOS; CRIANÇAS; ANTIBIÓTICOS (USO TERAPÊUTICO)
- Language: Inglês
- Imprenta:
- Source:
- Status:
- Artigo possui versão em acesso aberto em repositório (Green Open Access)
- Versão do Documento:
- Versão submetida (Pré-print)
- Acessar versão aberta:
-
ABNT
GOMEZ, David S. et al. Individualised vancomycin doses for paediatric burn patients to achieve PK/PD targets. Burns, v. 39, n. 3, p. 445-450. 2013, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.burns.2012.07.005. Acesso em: 16 abr. 2026. -
APA
Gomez, D. S., Campos, E. V., Azevedo, R. P. de, Silva-Jr, J. M. da, Ferreira, M. C., Sanches-Giraud, C., et al. (2013). Individualised vancomycin doses for paediatric burn patients to achieve PK/PD targets. Burns, 39( 3), 445-450. 2013. doi:10.1016/j.burns.2012.07.005 -
NLM
Gomez DS, Campos EV, Azevedo RP de, Silva-Jr JM da, Ferreira MC, Sanches-Giraud C, Silva-Jr CV, Santos SRCJ. Individualised vancomycin doses for paediatric burn patients to achieve PK/PD targets [Internet]. Burns. 2013 ; 39( 3): 445-450. 2013.[citado 2026 abr. 16 ] Available from: https://doi.org/10.1016/j.burns.2012.07.005 -
Vancouver
Gomez DS, Campos EV, Azevedo RP de, Silva-Jr JM da, Ferreira MC, Sanches-Giraud C, Silva-Jr CV, Santos SRCJ. Individualised vancomycin doses for paediatric burn patients to achieve PK/PD targets [Internet]. Burns. 2013 ; 39( 3): 445-450. 2013.[citado 2026 abr. 16 ] Available from: https://doi.org/10.1016/j.burns.2012.07.005 - Ciprofloxacin, oxacillin, piperacillin and sulfamethoxazole by systemic administration for the control of severe infections: is dose adjustment required for critical burn patients?
- Vancomycin dose adjustment in severe burn patients based on trough level for drug effectiveness against pathogens at 1 mg/l minimum inhibitory concentration
- A new carbapenem agent for the control of severe infection caused by the most agressive nosocomial strains in critically ill patients
- Imipenem pk/pd correlation for the control of pulmonary infection in critical burn patients with sepsis
- Pk/pd correlation for the control of infection by pseudomonas aeruginosa in critical burn patient: report case after electrical accident
- Imipenem serum measurements in real time for target attainment against more agressive strains MlC>2mg/l in septic burns
- Vancomycin prescription changes in real time based on drug plasma monitoring against Staphylococcus spp MlC 2mg/l in critically ill paediatric burns
- Triazoles or echinocandins antifungal therapy against candida glabrata in sepsis?
- PK/PD correlation for carbapenems for the control of nosocomial infection in critical burn pediatric patients
- PK modeling of vancomycin-piperacillin for the control of severe infections in critical burn patients for dose adjustment purpose
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
